MEDICAL DICTIONARY
Maroteaux-Lamy syndrome: A form of mucopolysaccharidosis with the clinical onset before age 3 that is characterized by an inability to metabolize dermatan sulfate. This leads to abnormal accumulation of dermatan sulfate, resulting in mild to severe changes in muscle, bone, skin, and other tissues, particularly the heart. Diagnosis is by examining leukocytes and cultured skin fibroblasts, or 24-hour urine collection to search for high levels of dermatan sulfate. There is no current treatment for the syndrome, but individual symptoms and problems may respond to physical therapy, medication, or surgery. Due to heart damage, death usually occurs before age 40. Also known as mucopolysaccharidosis type VI.
See also: Mucopolysaccharidosis .
|
DISCLAIMER:
Information on this site is provided for informational
purposes and is not meant to substitute for the advice
provided by your own physician or other medical professional.
You should not use the information contained herein
for diagnosing or treating a health problem or disease,
or prescribing any medication. You should read carefully
all product packaging. Not all Canadian drugs, Canada
prescription and Canadian prescription medicine is available
at discount Canadian on line pharmacies. If you have
or suspect that you have a medical problem, promptly
contact your health care provider. Information and statements
regarding diet supplements have not been evaluated by
Health Canada and are not intended to diagnose, treat,
cure, or prevent any disease. All trade and service
marks mentioned on this site are recognized as belonging
to their respective owners.
|
|
|
|
